
Environmental and Molecular Mutagenesis, Год журнала: 2025, Номер unknown
Опубликована: Март 4, 2025
ABSTRACT The current genotoxicity testing paradigm provides little mechanistic information, has poor specificity in predicting carcinogenicity humans, and is not suited to assessing a large number of chemicals. Genomic technologies enable the characterization genome‐wide transcriptional changes response chemical treatments that can inform mechanisms or modes action. These provided an impetus develop transcriptomic biomarkers could transform hazard assessment for drugs, cosmetics, environmental industrial In August 2022, International Workshops on Genotoxicity Testing (IWGT) held workshop critically review progress development application testing. Here, we describe findings this workshop's subgroup conducted systematized analysis vitro evaluating genotoxicity. Although there multitude published reports exploring transcriptomics genetic toxicology, working group identified only five biomarker candidates, which three (GENOMARK, TGx‐DDI, MU2012) were independently developed with sufficiently defined context use, validation data, supporting case studies warranted inclusion review. these different classes chemicals (TGx‐DDI pharmaceuticals, GENOMARK MU2012 medical chemicals), they all address same shortfall standard battery, is, lack by genotoxicity‐induced stress at level. review, discuss biomarkers, including challenges toward achieving regulatory acceptance.
Язык: Английский